0904-6821 : Tenofovir Disproxil Fumarate 300 mg Oral Tablet


NDC0904-6821
Labeler: Major Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name: Tenofovir Disproxil Fumarate
Dosage Form: Oral Tablet
Application #: ANDA203232
Rev. Date: 


Appearance:


Markings: CL77
Shapes:  Oval
Colors:  Blue
Size (mm): 17
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0904-6821-04: 30 BLISTER PACK IN 1 CARTON (0904‑6821‑04) > 1 TABLET IN 1 BLISTER PACK

Active Ingredients:

  • Tenofovir Disoproxil Fumarate

Dosage Strength:

  • 300 mg

Inactive Ingredients:

  • Croscarmellose Sodium
  • Lactose Monohydrate
  • Magnesium Stearate
  • Microcrystalline Cellulose
  • Starch, Corn
  • Fd&c Blue No. 2
  • Hypromellose, Unspecified
  • Titanium Dioxide
  • Triacetin /

Pharmaceutical Classes:

  • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]
  • Nucleosides [CS]

Related Products:

Based on records with the same trade name.
  • 33342-096 Tenofovir Disproxil Fumarate 300 mg Oral Tablet by Macleods Pharmaceuticals Limited

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0904-6821 QR Code

< Prev: 0904-6820Next: 0904-6822 >

Related Discussions:

Tenofovir with primolut N
Actually I am taking tenofovir from the past 2 years. Now I need to take primolut N. Can I take it with tenofovir? One o...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.